Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Engineered cartilage secretes anti-inflammatory drug

Feb. 2, 2021

Merck KGaA patents TLR antagonists

Jan. 28, 2021

First patients dosed in phase II study of GS-248 in systemic sclerosis

Jan. 27, 2021

Rinvoq approved in E.U. for psoriatic arthritis and ankylosing spondylitis

Jan. 26, 2021

Aclaris reports topline phase IIa data on ATI-450 for rheumatoid arthritis

Jan. 20, 2021

Clinical hold for planned phase I/II trial of HST-003 for knee cartilage regeneration

Jan. 20, 2021

Targeting the cartilage EGFR pathway is a promising therapeutic strategy in OA

Jan. 20, 2021

Eli Lilly initiates phase II study of LY-3462817 in rheumatoid arthritis

Jan. 19, 2021

SinoMab initiates phase I trial in China with SN-1011 for autoimmune disease

Jan. 18, 2021

PT-101 shows safety and ability to selectively expand Tregs in healthy volunteers

Jan. 5, 2021

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.